Bruno Gagnon
Corporate Officer/Principal en OPTHEA LIMITED .
Perfil
Bruno Gagnon is a professional with experience in various firms.
He is currently working as Senior Vice President-Global Clinical Operations at Opthea Ltd.
He has previously worked as Vice President-Clinical Operations at BioMarin Pharmaceutical, Inc. and as Senior Vice President-Development Operations at Eidos Therapeutics, Inc. Mr. Gagnon has completed his graduate degree from the University of Montréal and his undergraduate degree from Université Laval.
Cargos activos de Bruno Gagnon
| Empresas | Cargo | Inicio |
|---|---|---|
| OPTHEA LIMITED | Corporate Officer/Principal | 01/07/2022 |
Antiguos cargos conocidos de Bruno Gagnon.
| Empresas | Cargo | Fin |
|---|---|---|
| BIOMARIN PHARMACEUTICAL INC. | Director de Operaciones | - |
| EIDOS THERAPEUTICS, INC. | Director de Operaciones | - |
Formación de Bruno Gagnon.
| University of Montréal | Graduate Degree |
| Université Laval | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| OPTHEA LIMITED | Health Technology |
| BIOMARIN PHARMACEUTICAL INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Eidos Therapeutics, Inc.
 Eidos Therapeutics, Inc. BiotechnologyHealth Technology Eidos Therapeutics, Inc. focuses on addressing the large and growing unmet need in diseases caused by transthyretin (TTR) amyloidosis (ATTR). Its product include the AG10, an orally-administered small molecule designed to potently stabilize TTR, suggesting a treatment with the potential to halt the progression of ATTR. The company was founded by Graef Isabella and Alhamadsheh Mamoun on August 6, 2013 and is headquartered in San Francisco, CA. | Health Technology |
- Bolsa de valores
- Insiders
- Bruno Gagnon